Antinociceptive interactions between anandamide and endomorphin-1 at the spinal level

Clinical and Experimental Pharmacology and Physiology

Volumn 36, Issue 4, 2009, Pages 400-405

  Tuboly, Gabor ^a   Mecs, Laszlo ^b   Benedek, György ^a   Horvath, Gyöngyi ^a,c  

^a Department of Physiology ^*  (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

^c UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Anandamide; Cannabinoid; Endomorphin 1; Hyperalgesia; Interaction; Intrathecal; Pain

Indexed keywords

ANANDAMIDE; CANNABINOID 1 RECEPTOR AGONIST; ENDOMORPHIN 1; MU OPIATE RECEPTOR AGONIST;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG POTENCY; HYPERALGESIA; INFLAMMATION; MALE; NONHUMAN; RAT; STATISTICAL ANALYSIS;

ANALGESICS; ANIMALS; ARACHIDONIC ACIDS; CARRAGEENAN; DRUG COMBINATIONS; DRUG EVALUATION, PRECLINICAL; DRUG INTERACTIONS; HYPERALGESIA; INFLAMMATION; INJECTIONS, SPINAL; MALE; OLIGOPEPTIDES; PAIN; POLYUNSATURATED ALKAMIDES; RATS; RATS, WISTAR; SPINE; TIME FACTORS;

EID: 68849129544     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2008.05081.x     Document Type: Article

References (43)

1. Kristensen JD, Post C, Gordh TJ, Svensson BA. Spinal cord morphology and antinociception after chronic intrathecal administration of excitatory amino acid antagonists in the rat. Pain 1993 54 : 309 16.
2. Fields HL, Heinricher MM, Mason P. Neurotransmitters in nociceptive modulatory circuits. Annu. Rev. Neurosci. 1991 14 : 219 45.
3. Csullog E, Joo G, Toth G, Dobos I, Benedek G, Horvath G. Antinociceptive effect of continuous intrathecal administration of endomorphin-1. Pain 2001 94 : 31 8.
4. Kekesi G, Horvath G, Joo G et al. The antinociceptive effect of intrathecal kynurenic acid and its interaction with endomorphin-1 in rats. Eur. J. Pharmacol. 2002 445 : 93 6.
5. Kekesi G, Dobos I, Benedek G, Horvath G. The antinociceptive potencies and interactions of endogenous ligands during continuous intrathecal administration: Adenosine, agmatine, and endomorphin-1. Anesth. Analg. 2004 98 : 420 6.
6. Zadina JE, Hackler L, Ge L-J, Kastin AJ. A potent and selective endogenous agonist for the μ-opiate receptor. Nature 1997 386 : 499 502.
7. Stone LS, Fairbanks CA, Laughlin TM et al. Spinal analgesic actions of the new endogenous opioid peptides endomorphin-1 and -2. Neuroreport 1997 8 : 3131 5.
8. Horvath G, Szikszay M, Tomboly C, Benedek G. Antinociceptive effects of intrathecal endomorphin-1 and -2 in rats. Life Sci. 1999 65 : 2635 41.
9. Horvath G, Kekesi G. Interaction of endogenous ligands mediating antinociception. Brain Res. Rev. 2006 52 : 69 92.
10. Pertwee RG. Cannabinoid receptors and pain. Prog. Neurobiol. 2001 63 : 569 611.
11. Hohmann AG. Spinal and peripheral mechanisms of cannabinoid antinociception. Behavioral, neurophysiological and neuroanatomical perspectives. Chem. Phys. Lipids 2002 121 : 173 90.
12. Walker JM, Krey JF, Chu CJ, Huang SM. Endocannabinoids and related fatty acid derivates in pain modulation. Chem. Phys. Lipids 2002 121 : 159 72.
13. Carlini EA. The good and the bad effects of (-)trans-delta-9- tetrahydrocannabinol ([Delta]9-THC) on humans. Toxicon 2004 44 : 461 7.
14. Devane WA, Hanus L, Breuer A et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 1992 258 : 1946 9.
15. Hajos N, Ledent C, Freund TF. Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus. Neuroscience 2001 106 : 1 4.
16. Oz M. Receptor-independent actions of cannabinoids on cell membranes: Focus on endocannabinoids. Pharmacol. Ther. 2006 111 : 114 44.
17. Tognetto M, Amadesi S, Harrison S et al. Anandamide excites central terminals of dorsal root ganglion neurons via vanilloid receptor-1 activation. J. Neurosci. 2001 21 : 1104 9.
18. 2+ influx via TRPV1 channels. EMBO J. 2005 24 : 3517 18.
19. Zygmunt PM, Petersson J, Andersson DA et al. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature 1999 400 : 452 7.
20. Di Marzo V, Blumberg PM, Szallasi A. Endovanilloid signaling in pain. Curr. Opin. Neurobiol. 2002 12 : 372 9.
21. Morisset V, Ahluwalia J, Nagy I, Urban L. Possible mechanisms of cannabinoid-induced antinociception in the spinal cord. Eur. J. Pharmacol. 2001 429 : 93 100.
22. Horvath G, Kekesi G, Nagy E, Benedek G. The role of TRPV1 receptors in the antinociceptive effect of anandamide at spinal level. Pain 2007 134 : 277 84.
23. Welch SP, Eads M. Synergistic interactions of endogenous opioids and cannabinoid systems. Brain Res. 1999 848 : 183 90.
24. Yaksh TL, Rudy TA. Chronic catheterization of the spinal subarachnoid space. Physiol. Behav. 1976 17 : 1031 6.
25. Dobos I, Toth K, Kekesi G et al. The significance of intrathecal catheter location in rats. Anesth. Analg. 2003 96 : 487 92.
26. Hargreaves K, Dubner R, Brown F, Flores C, Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 1988 32 : 77 88.
27. Tallarida RJ, Porreca F, Cowan A. Statistical analysis of drug-drug and site-site interactions with isobolograms. Life Sci. 1989 45 : 947 61.
28. Harris J, Drew LJ, Chapman V. Spinal anandamide inhibits nociceptive transmission via cannabinoid receptor activation in vivo. Neuroreport 2001 12 : 2817 19.
29. 2 release. J. Pharmacol. Exp. Ther. 2006 316 : 466 75.
30. Welch SP, Huffman JW, Lowe J. Differential blockade of the antinociceptive effects of centrally administered cannabinoids by SR14176A. J. Pharmacol. Exp. Ther. 1998 286 : 1301 8.
31. 2 receptor-mediated actions of anandamide in mouse brain. J. Neurochem. 2000 75 : 2434 44.
32. Jancsó G, Jancsó-Gábor A. Effect of capsaicin on morphine analgesia: Possible involvement of hypothalamic structures. Arch. Pharmacol. 1989 311 : 285 8.
33. Hayes AG, Tyers MB. Effects of capsaicin on nociceptive heat, pressure and chemical thresholds and substance P levels in the rat. Brain Res. 1980 189 : 561 4.
34. Jancsó G, Király E, Joó F, Such G, Nagy A. Selective degeneration by capsaicin of a subpopulation of primary sensory neurons in the adult rat. Neurosci. Lett. 1985 59 : 209 14.
35. Bach FW, Yaksh TL. Release of β-endorphin immunoreactivity into ventriculo-cisternal perfusate by lumbar intrathecal capsaicin in the rat. Brain Res. 1995 701 : 192 200.
36. Szolcsányi J, Helyes Z, Oroszi G, Németh J, Pintér E. Release of somatostatin and its role in the mediation of the anti-inflammatory effect induced by antidromic stimulation of sensory fibres of rat sciatic nerve. Br. J. Pharmacol. 1998 123 : 936 42.
37. Jerman JC, Gray J, Brough SJ et al. Comparison of effects of anandamide at recombinant and endogenous rat vanilloid receptors. Br. J. Anaesth. 2002 89 : 882 7. (Pubitemid 35460527)
38. 1 and VR1 spinal receptors in urethane-anesthetized rats. Naunyn Schmiedebergs Arch. Pharmacol. 2003 368 : 270 6.
39. Szallasi A, Blumberg PM. Vanilloid (capsaicin) receptors and mechanisms. Pharmacol. Rev. 1999 51 : 159 211.
40. 3 receptor-mediated responses in Xenopus oocytes. Synapse 2002 46 : 150 6.
41. + currents in rat dorsal root ganglion neurons. Brain Res. 2005 1062 : 39 47. (Pubitemid 41612127)
42. Hejazi N, Zhou C, Oz M, Sun H, Ye JH, Zhang L. {Delta}9- tetrahydrocannabinol and endogenous cannabinoid anandamide directly potentiate the function of glycine receptors. Mol. Pharmacol. 2006 69 : 991 7.
43. Lozovaya N, Yatsenko N, Beketov A, Tsintsadze T, Burnashev N. Glycine receptors in CNS neurons as a target for nonretrograde action of cannabinoids. J. Neurosci. 2005 25 : 7499 506.